Bristol, City of Medical Equipments, Pharmaceuticals and Personal Care Products Tenders & Contracts

The Cellular and Molecular Therapies (CMT) function within NHS Blood and Transplant (NHSBT) is responsible for the routine provision of stem cells for transplantation across England. We are also experts in providing development and manufacturing services for Advanced Therapies Medicinal Products (ATMPs). CMT also includes the Clinical Biotechnology Centre, which manufactures GMP-grade DNA plasmids and viral vectors. Our experience in the processing and storage of stem cells for transplant and the manufacture of clinical grade advanced cellular and molecular therapies, combined with our strong links to clinicians and hospitals, means we can help bring new and ground-breaking treatments to the bedside. The organisation intends to initiate a procurement for the supply of new and maintenance of new and existing cryogenic temperature data loggers for dry shippers. CMT receive and issue cellular products nationally in the UK. To maintain optimal cell viability, it is vital that these products remain within strict temperature limits during transit. As such there is a requirement to monitor the internal conditions of all transport containers used to move temperature-controlled products between facilities. Within CMT there are currently six laboratories that are required to issue stem cell products. These are in Barnsley, Birmingham, Filton, Oxford, Liverpool and Southampton.

The Cellular and Molecular Therapies (CMT) function within NHS Blood and Transplant (NHSBT) is responsible for the routine provision of stem cells for transplantation across England. We are also experts in providing development and manufacturing services for Advanced Therapies Medicinal Products (ATMPs). CMT also includes the Clinical Biotechnology Centre, which manufactures GMP-grade DNA plasmids and viral vectors. Our experience in the processing and storage of stem cells for transplant and the manufacture of clinical grade advanced cellular and molecular therapies, combined with our strong links to clinicians and hospitals, means we can help bring new and ground-breaking treatments to the bedside. The organisation intends to initiate a procurement for the supply of new and maintenance of new and existing cryogenic temperature data loggers for dry shippers. CMT receive and issue cellular products nationally in the UK. To maintain optimal cell viability, it is vital that these products remain within strict temperature limits during transit. As such there is a requirement to monitor the internal conditions of all transport containers used to move temperature-controlled products between facilities. Within CMT there are currently six laboratories that are required to issue stem cell products. These are in Barnsley, Birmingham, Filton, Oxford, Liverpool and Southampton.

What DVSA want to achieve The purpose of this preliminary market engagement notice is to notify the market that Driver and Vehicle Standards Agency (DVSA) will seek to find a single supplier for the provision of services relating to the collection and selling of redundant DVSA testing equipment. DVSA will continue to reduce the volume of its Government Vehicle Testing Station (GVTS) Estates in accordance with observed incremental growth rate in the Authorised Testing Facilities (ATF’s) market and moving the Individual Vehicle Approval (IVA) scheme out to privately owned sites called Vehicle Examination Facilities (VEF’s). This move was set up to bring the work that DVSA conduct closer to Vehicle Operators and Vehicle Maintainers; by encouraging private individuals and entrepreneurs to set up an ATF’s and/or VEFs for private and public use. This was a strategic and positive shift in the way DVSA conducts its vehicle testing business. As a result of this initiative DVSA testing equipment will become redundant and require the equipment to be sold on our behalf. All the equipment to be sold was previously decommissioned from DVSA’s GVTS and Enforcement sites network throughout Great Britain. Due to the complexity of the how sites will be closed it is not possible at this time to disclose the location of the equipment and when it will require to be collected ahead of being sold. The equipment that DVSA that will have been decommissioned in a safe manner to enable it to be re-sold comprises of, but not limited to: Roller Brake Testers (for light vehicles, heavy vehicles and motorcycles) Headlight Testers Speedrollers 4 Post Lifts Motorcycle Lifts Pit Jacks Air Compressors Load Simulators Wheel Play Detectors Exhaust Extraction Units Emission Testers Cabin Pressurisation Units The specification will also include full details of how it will be required to be collected and sold; it will not be possible to keep this equipment at the sites ahead of being sold so must be kept at the awarded suppliers premises ahead of being sold.